Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Corrigendum to "The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies" [Lung Cancer 204 (2025) 108585].

Created on 06 Sep 2026

Authors

Prasanth Sekar, Ashmitha Ashok Kumar, Ian Hughes, Robert Mason, Marcin Dzienis

Published in

Lung cancer (Amsterdam, Netherlands). Pages 109598. Sep 05, 2026. Epub Sep 05, 2026.

PMID:
42701067
Bibliographic data and abstract were imported from PubMed on 06 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement